Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenkangling for Renal Ischemia-reperfusion Injury
NCT07153731Phase 4Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2025
- Primary completion
- Oct 2025
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Shenkangling in renal ischemia-reperfusion injury, sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Shenkangling
03
Conditions
renal ischemia-reperfusion injury
Beyond the preview
Go deeper on NCT07153731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07153731.